49 Proteomic analysis of the mechanism of action of a COX2 Inhibitor (DuP-697) in mesothelioma by Agarwal, V, Hodgkinson, V.C, Eagle, G.L, Scaife, L, Lind, M.J, Cawkwell, L

Get full text

G.P.13.11 Oral bisphosphonates as prophylaxis of steroid-induced osteoporosis in Duchenne muscular dystrophy by Sarkozy, A, Cheetham, T, Pearce, S, Rawlings, D, Eagle, M, Vita, G.L, Guglieri, M, Straub, V, Bushby, K

Get full text

T.P.3.05 Reproducibility and correlation of pretreatment outcome measures in phase 2b study of ataluren (PTC124™ ) in nonsense mutation Duchenne and Becker muscular dystrophy (nmDM... by Florence, J, Abresch, R.T, Eagle, M, Gappmaier, E, Glanzman, A.M, Henricson, E, Reha, A, Elfring, G.L, Miller, L.L, Atkinson, L

Get full text

M.P.3.04 Assessment of StepWatch™ activity monitoring in phase 2b study of ataluren (PTC124™) in nmDMD/BMD by McDonald, C, Coleman, K, Henricson, E, Abresch, R.T, Eagle, M, Florence, J, Gappmaier, E, Glanzman, A.M, Reha, A, Elfring, G.L, Miller, L.L, Atkinson, L

Get full text

Molecular and supramolecular structure of 4,4'-bipyridinium diiodide by Iyere, P.A., Kayren, L.J., Cordes, A.W., Eagle, C.T., Nile, T.A., Schimek, G.L., Pennington, W.T.

Get full text